Hepatitis B: all 1,662 studies
Page 7 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS TreatmentStatus unknownNCT05382013Phase 4
- The Study on Optimal Treatment and Clinical Outcome of Chronic Hepatitis B Patients With Inactive HypoviremiaStatus unknownNCT05357235
- The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With HypoviremiaStatus unknownNCT05357183
- Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in SerumCompletedNCT05355467Phase 4
- Efficacy of VTP-300 in Chronic Hepatitis B InfectionCompletedNCT05343481Phase 2
- Discontinuation of Antiviral Therapy as a Strategy to Cure Hepatitis BActive, not recruitingNCT05328427Not applicable
- Intralesional Versus Intramuscular Hepatitis B Vaccine Immunotherapy for WartsCompletedNCT05326152Phase 1/2
- Steatohepatitis in Chronic Hepatitis BCompletedNCT05317260
- The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With TDFCompletedNCT05313477Phase 4
- Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult SubjectsCompletedNCT05310487Phase 1
- Ethnobridging Study in Healthy Volunteers, Chinese and Japanese SubjectsTerminatedNCT05298332Phase 1
- Performance of Novel Simplified Score for Chronic Hepatitis B Treatment Eligibility in ThailandStatus unknownNCT05295914
- Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis BCompletedNCT05286346Phase 4
- The Effect of Education on Drug Compliance and Quality of Life in Hepatitis B PatientsStatus unknownNCT05286216Not applicable
- A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis BCompletedNCT05282407Phase 4
- A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) TherapyCompletedNCT05276297Phase 2
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy VolunteersCompletedNCT05275465Phase 1
- HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal CentersTerminatedNCT05272735Phase 4
- Aerobic Exercise Training in Patients With Chronic Hepatitis B and Hepatic SteatosisCompletedNCT05265026Not applicable
- Disease Loads and Status of TreatmentStatus unknownNCT05264272
- Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis BStatus unknownNCT05256823Phase 2
- Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular CarcinomaStatus unknownNCT05256459
- A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B PatientsCompletedNCT05244057Phase 2
- A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus InfectionCompletedNCT05242445Phase 1
- A Study of Safety and Efficacy of ATI-2173 and Vebicorvir in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus InfectionTerminatedNCT05238844Phase 2
- Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus InfectionCompletedNCT05229991Phase 3
- Continuing Medical Education to Improve Knowledge of Viral Hepatitis B-C in Primary Healthcare WorkersStatus unknownNCT05207163Not applicable
- Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low ViremiaStatus unknownNCT05203055Phase 1/2
- Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy SubjectsCompletedNCT05189288Phase 1
- Testing and Epidemiology of Delta HepatitisStatus unknownNCT05181956
- Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)Status unknownNCT05177926Phase 4
- Effect of Entecavir Versus Tenofovir on HBV DNA Level in Peripheral Blood Mononuclear CellsStatus unknownNCT05168293
- Evaluation of Hepatitis B Virus (HBV) DNA Test As Point of Care ToolCompletedNCT05144776
- A Study of LP-128 Capsules in Healthy SubjectsActive, not recruitingNCT05130567Phase 1
- Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its ComplicationStatus unknownNCT05128305Phase 3
- Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention CenterCompletedNCT05127187Not applicable
- A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus InfectionCompletedNCT05123599Phase 1
- Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B InfectionCompletedNCT05117541
- Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.CompletedNCT05115942Phase 3
- Study to Evaluate Safety and Efficacy of ASC42 Combined With ETV and PEG-IFN α-2a in Subjects With HBVCompletedNCT05107778Phase 2
- The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College StudentsStatus unknownNCT05099757Phase 4
- T-cell Dysfunction in Chronic HBV InfectionStatus unknownNCT05099458Not applicable
- Prevention of HCC Using Mobile Phone ApplicationsStatus unknownNCT05094869
- Re-compensation and Its Clinical Characteristics in HBV Decompensated CirrhosisStatus unknownNCT05086536
- ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased RiskActive, not recruitingNCT05064553
- A Clinical Research on Disease Progression and Intervention of Chronic HepatitisBStatus unknownNCT05057065
- ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Stimulation Followed by NUC DiscontinuationStatus unknownNCT05045261Phase 2
- Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine RegimenStatus unknownNCT05028322Phase 2
- A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT05017116Phase 1
- Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)CompletedNCT05002907
- A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB SubjectsTerminatedNCT05001022Phase 1
- Stop Hep B @ BirthStatus unknownNCT04998838Not applicable
- The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in ChinaStatus unknownNCT04997564Phase 4
- Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of ChinaStatus unknownNCT04980664Not applicable
- Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic ImpairmentCompletedNCT04971928Phase 1
- A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.TerminatedNCT04971512Phase 1
- Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University HospitalStatus unknownNCT04959643
- Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)Active, not recruitingNCT04954859Phase 2
- Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the CommunityCompletedNCT04947475Not applicable
- Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)Active, not recruitingNCT04939441Phase 4
- Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021CompletedNCT04939350
- Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy SubjectsCompletedNCT04906109Phase 1
- Access HBV Assays - European Union (EU) Clinical Trial Protocol -CompletedNCT04904835
- Cameroon HepB Birth Dose Feasibility PilotCompletedNCT04893616Not applicable
- The Impact of Tenofovir Alafenamide on Profiles of Body Weight and Metabolic Features in Chronic Hepatitis B Patients.Status unknownNCT04886336
- Molecular Epidemiology of Hepatitis B in Cayenne General Hospital, French GuianaStatus unknownNCT04886102
- Hepatitis B Birth Dose for NewbornsCompletedNCT04870021Phase 4
- Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 TabletsCompletedNCT04868981Phase 1
- Efficacy and Safety of TAF for 48 Weeks in HBeAg Positive CHB PatientsStatus unknownNCT04864366
- Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)Active, not recruitingNCT04863703
- Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus InfectionCompletedNCT04856085Phase 2
- Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis BStatus unknownNCT04850950Phase 4
- A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus CoinfectionTerminatedNCT04847440Phase 2
- A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis BCompletedNCT04846491Phase 3
- Predictive Model for Prognosis of Chronic HBV Infection MothersStatus unknownNCT04805034
- Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy SubjectsCompletedNCT04783753Phase 1
- Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA LevelsActive, not recruitingNCT04780204Phase 4
- COIN-B: COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B InfectionsActive, not recruitingNCT04779970Not applicable
- Evaluation of Liver Fibrosis With 2D-Shear Wave ElastographyCompletedNCT04759521
- Thromboelastography Guides a Multicentre Cluster Controlled Study of Plasma Exchange for Hepatitis B Associated Acute-on-chronic Liver FailureStatus unknownNCT04747106Not applicable
- Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB PatientsStatus unknownNCT04724785
- Spirulina (FEM-102) Supplement to Chronic Hepatitis B PatientsCompletedNCT04718831Not applicable
- Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib AloneCompletedNCT04710641Phase 2
- Reducing Vertical Transmission of Hepatitis B in AfricaActive, not recruitingNCT04704024Phase 3
- Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy SubjectsStatus unknownNCT04676893Phase 1
- Prevalence of Occult Hepatitis B Virus Infection（OBI） in Subjects With Chronic Hepatitis B（CHB） Family HistoryStatus unknownNCT04672915
- Nurse-led Decision Counseling on Hepatocellular Carcinoma ScreeningCompletedNCT04659005Not applicable
- TDF Combined With LDT for the Treatment of HBeAg-positive Hepatitis B Patients With Poor Response to TDF for 12 MonthsStatus unknownNCT04650828
- Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B PatientsStatus unknownNCT04646928
- LDT Combined With TDF to Improve EGFR Decreasing in Patients With Chronic Hepatitis B Treated With TDFStatus unknownNCT04643990
- A Study to Evaluate the Mass Balance Absorption and AME of VBRCompletedNCT04637139Phase 1
- Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis BCompletedNCT04629976Phase 1
- Combi-elastography Assessment of Chronic Liver Disease Multi-center StudyStatus unknownNCT04625166
- TAF to Prevent HBV Reactivation in Cancer PatientsActive, not recruitingNCT04619082Phase 4
- Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 DiabetesStatus unknownNCT04584242Phase 4
- Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 YearsStatus unknownNCT04565262Phase 4
- GLS4/RTV and TAF Drug-drug InteractionCompletedNCT04551261Phase 1
- Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in CirrhosisStatus unknownNCT04543643Phase 3
- Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 StudyStatus unknownNCT04543565Phase 3
- Immunogenicity of the Hepatitis B VaccineStatus unknownNCT04540653Phase 4